DK1809661T3 - Humant interferon-beta-mutein - Google Patents

Humant interferon-beta-mutein

Info

Publication number
DK1809661T3
DK1809661T3 DK05804508.9T DK05804508T DK1809661T3 DK 1809661 T3 DK1809661 T3 DK 1809661T3 DK 05804508 T DK05804508 T DK 05804508T DK 1809661 T3 DK1809661 T3 DK 1809661T3
Authority
DK
Denmark
Prior art keywords
beta
human interferon
mutein
relates
present
Prior art date
Application number
DK05804508.9T
Other languages
Danish (da)
English (en)
Inventor
Jong-Min Lee
Moon Kyoung So
Kyung Song
Jae Ho Jin
Young Kee Shin
Ji Tai Kim
Ji Soo Ahn
Tae Ho Byun
Ho Chul Yoon
Ji-Hye Yang
Han Kyu Oh
Ji Uk Yoo
Original Assignee
Young Kee Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Young Kee Shin filed Critical Young Kee Shin
Application granted granted Critical
Publication of DK1809661T3 publication Critical patent/DK1809661T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05804508.9T 2004-11-02 2005-11-02 Humant interferon-beta-mutein DK1809661T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040088196A KR100781666B1 (ko) 2004-11-02 2004-11-02 인간 인터페론-베타 변이체
PCT/KR2005/003665 WO2006049423A1 (en) 2004-11-02 2005-11-02 Human interferon-beta mutein

Publications (1)

Publication Number Publication Date
DK1809661T3 true DK1809661T3 (da) 2011-09-05

Family

ID=36319397

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05804508.9T DK1809661T3 (da) 2004-11-02 2005-11-02 Humant interferon-beta-mutein

Country Status (11)

Country Link
US (1) US8101716B2 (pt)
EP (1) EP1809661B1 (pt)
JP (1) JP4637913B2 (pt)
KR (1) KR100781666B1 (pt)
CN (1) CN101111519B (pt)
AT (1) ATE509951T1 (pt)
BR (1) BRPI0517932B1 (pt)
DK (1) DK1809661T3 (pt)
ES (1) ES2369088T3 (pt)
PT (1) PT1809661E (pt)
WO (1) WO2006049423A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020580A2 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
BRPI0810622A2 (pt) 2007-05-02 2020-10-13 Ambrx, Inc. polipeptídeos de interferon beta modificados e seus usos
CN102260344A (zh) * 2010-05-26 2011-11-30 重庆富进生物医药有限公司 缺失型人β干扰素及其重组制备
KR101979045B1 (ko) * 2011-10-01 2019-05-15 가부시키가이샤 도우사 고가쿠 겐큐쇼 당쇄 부가 폴리펩티드 및 상기 폴리펩티드를 포함하는 의약 조성물
SG11201507769SA (en) 2013-03-29 2015-10-29 Glytech Inc Polypeptide having sialylated sugar chains attached thereto
AU2015239104B2 (en) * 2014-04-04 2018-12-20 Ares Trading S.A. Novel IFN beta protein analogs
US11759500B2 (en) * 2014-07-24 2023-09-19 Abion Inc. PEGylated interferon-beta variant
WO2016013697A1 (ko) * 2014-07-24 2016-01-28 에이비온 주식회사 인터페론-베타 변이체의 폴리에틸렌글리콜 배합체
US20210009720A1 (en) * 2015-03-03 2021-01-14 Genopharm Inc. Human interferon-beta variant conjugated immunocytokine and method for preparing same
KR101838919B1 (ko) * 2015-03-03 2018-03-15 에이비온 주식회사 인간 인터페론-베타 변이체가 접합된 면역사이토카인 및 이의 제조방법
WO2016163764A2 (ko) * 2015-04-07 2016-10-13 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
KR102666000B1 (ko) 2016-07-29 2024-05-14 서울대학교 산학협력단 cFLIP siRNA를 포함하는 인터페론 베타 저항성 암 질환 치료용 또는 감작용 조성물
KR101943160B1 (ko) 2016-10-06 2019-01-30 에이비온 주식회사 인터페론 베타 변이체의 안정화 제제
KR101955366B1 (ko) 2017-06-02 2019-03-07 인제대학교 산학협력단 인터페론 베타-엘라스틴 재조합 단백질 및 이의 생산방법
CN108117595B (zh) * 2018-02-28 2020-06-26 中国科学院微生物研究所 一种犬α干扰素的制备及其应用
KR20210021861A (ko) * 2019-08-19 2021-03-02 (주)제노팜 사람 표피성장인자수용체 2 양성 암을 치료하기 위한 인터페론-베타 변이체 면역사이토카인의 용도 및 환자 선별 방법
CA3177028A1 (en) 2020-04-29 2021-11-04 Jun Young Choi Human interferon-beta variant with double mutation and method for improving stability of human interferon-beta variant
CN116075523A (zh) * 2020-04-29 2023-05-05 基因制药株式会社 具有融合的干扰素-β突变蛋白和抗体的重组蛋白以及包含其的药物组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
DE19717864C2 (de) 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US6531122B1 (en) * 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
EP1549675B1 (en) * 2002-08-31 2008-02-13 CJ Corp Glycosylated human interferon alpha isoform
WO2004031352A2 (en) * 2002-10-01 2004-04-15 Xencor, Inc. Interferon variants with improved properties
KR100541850B1 (ko) * 2003-03-31 2006-01-11 삼성정밀화학 주식회사 인간 인터페론-베타 변이체 및 그의 제조방법

Also Published As

Publication number Publication date
EP1809661A1 (en) 2007-07-25
JP2008518631A (ja) 2008-06-05
CN101111519A (zh) 2008-01-23
WO2006049423A1 (en) 2006-05-11
EP1809661B1 (en) 2011-05-18
BRPI0517932A8 (pt) 2018-05-02
PT1809661E (pt) 2011-09-05
ES2369088T3 (es) 2011-11-25
JP4637913B2 (ja) 2011-02-23
US20100003721A1 (en) 2010-01-07
US8101716B2 (en) 2012-01-24
BRPI0517932A (pt) 2008-10-21
KR20060039132A (ko) 2006-05-08
ATE509951T1 (de) 2011-06-15
KR100781666B1 (ko) 2007-12-03
BRPI0517932B1 (pt) 2021-10-19
EP1809661A4 (en) 2008-02-06
CN101111519B (zh) 2012-11-07

Similar Documents

Publication Publication Date Title
DK1809661T3 (da) Humant interferon-beta-mutein
CA109169S (en) Sphygmomanometer
ATE427763T1 (de) Ballonkatheter
BRPI0519046A2 (pt) composição de xampu
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
ATE382778T1 (de) Pumpenkombination
AU301493S (en) Reciprocating saw
ATE465741T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
NL1026326A1 (nl) Patient-ligtafel.
FR2858695B1 (fr) Calculateur personnel.
CA113897S (en) Traction chain
ES1051639Y (es) Mesa de juegos.
BR8201883Y1 (pt) disposição construtiva em embalagem.
ES1058159Y (es) Taco.
BR0200192B1 (pt) cingento com três pontos de fixação.
NI200400017S (es) Diseño caramelo duro
ES1057262Y (es) Pareo pantalon.
ES1058437Y (es) Mesa.
BR8203451Y1 (pt) disposição construtiva em copo descartável.
ES1056067Y (es) Mesa suplementable.
ITRM20020505A1 (it) Pasta ipersalina.
AU300892S (en) Tables
ES1056890Y (es) Mesa de oficina.
BR0203121B1 (pt) disposição construtiva introduzida em estrutura de luminária.